KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

Systems (NASDAQ: KRMD), a medical technology firm with a market capitalization of $194 million, announced a partnership with a global pharmaceutical manufacturer to conduct a Phase III clinical trial.

The Barbara Ann Karmanos Cancer Institute has opened the Karmanos Cancer Institute — Dearborn along Hubbard Drive, just west ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.